A few studies demonstrated that RAB42 is expressed in mucinous lung adenocarcinoma, breast cancer, glioma, and LIHC (Di Carlo et al., 2020; Yang Y. et al., 2021; Liu et al., 2021; Kong et al., 2023). Here, RAB42 is linked to breast cancer.